Safety and efficacy of ravulizumab in patients with NMOSD previously treated with rituximab: A post hoc analysis of the CHAMPION-NMOSD trial
J.L. Bennett, Aram Zabeti, Becky Jo Parks, Shamik Bhattacharyya et al.
Journal
Multiple Sclerosis Journal
Topics
Peripheral Neuropathies and Disorders
article
Safety and efficacy of ravulizumab in patients with NMOSD previously treated with rituximab: A post hoc analysis of the CHAMPION-NMOSD trial
J.L. Bennett, Aram Zabeti, Becky Jo Parks, Shamik Bhattacharyya, J de Sèze, U Akpoji, M J Taney, M Levy, K Allen, S J Pittock
article en
Abstract
No abstract available for this paper.
Publication Tag
Multiple Sclerosis Journal
Institutions
Mayo Clinic (US), Massachusetts General Hospital (US), Mayo Clinic in Arizona (US), Alexion Pharmaceuticals (United States) (US), Mayo Clinic in Florida (US), AstraZeneca (United States) (US), Hôpital Civil, Strasbourg (FR), University of Colorado Anschutz Medical Campus (US), University of Cincinnati (US)